CountriesUK

Products 1 to 10 of 10

BIO-SA Based Resins & Coatings by BioAmber, Inc.
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: Benelux + France + Iberia + Germany + Poland + Switzerland + UK + Ireland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:30 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product
Biotech components: Animal
Business models: B2B
Country of production: UK
Country of distribution: England + USA
Intended consumer: Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 36,300,000 USD
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Other
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Lux Algal Oil Soap by Lux (Unilever)
Biotech components: Plant
Business models: B2C
Country of production: UK
Country of distribution: Brazil + UK
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: ULVR (LSE)
Value chain stage: Finished Product
nC4-OL (Renewable n-Butanol) by Green Biologics
Biotech components: Plant
Business models: B2B
Country of production: UK
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/01/30 11:58 (6 years ago)
Known funding amount: 120,100,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Phyzyme XP Phytase by DuPont + Danisco
Biotech components: Bacteria
Business models: B2B
Country of production: USA + Denmark
Country of distribution: UK
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Feed
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
SigNature DNA by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA + Turkey + Africa + UK
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/01/30 12:01 (6 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: On the market
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Finished Product
Vaxonella by Prokarium
Biotech components: Bacteria
Business models: B2C
Country of production: UK
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/05/15 16:12 (6 years ago)
Known funding amount: 12,600,000 USD
Funding types: Venture Capital
Industry: Health
Market status: On the market + Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Molecule
Business models: B2C
Country of production: UK
Country of distribution: UK
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Security
Market status: On the market
Organization type(s): Private Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Zemea® 1,3-Propanediol by DuPont + Tate & Lyle Bio Products
Biotech components: Plant
Business models: B2B
Country of production: USA + UK
Country of distribution: USA + Asia Pacific + Europe
Intended consumer: Consumer + Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Zemea USP by DuPont + Tate & Lyle Bio Products
Biotech components: Plant
Business models: B2B
Country of production: USA + UK
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/19 16:00 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Health + Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Additive + Chemical + Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input